Table 2: Patient characteristics at the time of relapse or progression treated with high dose thiotepa.

Number of patients%

Patient characteristics
 Age, years
  Median15.9
  Range4 to 31
Disease status at study entry
 Refractory disease24.4
 First relapse2657.8
 Subsequent relapse 1737.8
Site of last relapse
 Lung only2351
 Lung + another site1533
 Bone only12.2
 Other49.3
Relapse operability
 Operable2046.5
 Inoperable2353.5
 Missing value2
Radiological response
 Partial response1230.8
 Stable disease1846.2
 Progressive disease923.1
 Not evaluable6
Histological response after thiotepa
 Good response929.0
 Poor response2271.0
 No surgery14